Paper · 97089
Analysis of the repertoire of anti-NP antibodies in C57BL/6 mice by cell fusion. I. Characterization of antibody families in the primary and hyperimmune response.
Reth M and 2 others. Eur J Immunol, 1978. Cited by 311 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Analysis of the repertoire of anti-NP antibodies in C57BL/6 mice by cell fusion. I. Characterization of antibody families in the primary and hyperimmune response. Papers, record 97089. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/97089
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Analysis of the repertoire of anti-NP antibodies in C57BL/6 mice by cell fusion. I. Characterization of antibody families in the primary and hyperimmune response.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibody Specificity | Major topic |
| Haptens | Major topic |
| Hybrid Cells | Major topic |
| Nitrophenols | Major topic |
| Animals | |
| Antibody Formation | |
| Cell Fusion | |
| Cell Line | |
| Genes | |
| Immunoglobulin Variable Region | |
| Immunoglobulin gamma-Chains | |
| Immunoglobulin lambda-Chains | |
| Immunoglobulin mu-Chains | |
| Mice | |
| Mice, Inbred BALB C | |
| Mice, Inbred C57BL | |
| Multiple Myeloma |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References0
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
None in this release.
Cited by109
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 311 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,609,039 | Growing up as an Immunologist Among Molecular Geneticists. | Eur J Immunol | 2026 | https://conductscience.org/library/papers/42609039 | PubMed |
| 39,942,636 | Affinity Maturation for Antibody Engineering: The Critical Role of Residues on CDR Loops of Antibodies in Antigen Binding. | Molecules | 2025 | https://conductscience.org/library/papers/39942636 | PubMed |
| 38,807,193 | TRPV1 nociceptors are required to optimize antigen-specific primary antibody responses to novel antigens. | Bioelectron Med | 2024 | https://conductscience.org/library/papers/38807193 | PubMed |
| 38,001,360 | Selection, characterization and in vivo evaluation of novel CD44v6-targeting antibodies for targeted molecular radiotherapy. | Sci Rep | 2023 | https://conductscience.org/library/papers/38001360 | PubMed |
| 37,544,964 | A dual function for the chromatin organizer Special A-T rich Binding Protein 1 in B-lineage cells. | Cell Mol Immunol | 2023 | https://conductscience.org/library/papers/37544964 | PubMed |
| 37,081,131 | Recreation of an antigen-driven germinal center in vitro by providing B cells with phagocytic antigen. | Commun Biol | 2023 | https://conductscience.org/library/papers/37081131 | PubMed |
| 36,893,259 | KMT2D acetylation by CREBBP reveals a cooperative functional interaction at enhancers in normal and malignant germinal center B cells. | Proc Natl Acad Sci U S A | 2023 | https://conductscience.org/library/papers/36893259 | PubMed |
| 36,813,795 | Antigen footprint governs activation of the B cell receptor. | Nat Commun | 2023 | https://conductscience.org/library/papers/36813795 | PubMed |
| 34,957,576 | Biogenesis of secretory immunoglobulin M requires intermediate non-native disulfide bonds and engagement of the protein disulfide isomerase ERp44. | EMBO J | 2022 | https://conductscience.org/library/papers/34957576 | PubMed |
| 34,389,622 | Continuous Culture of Mouse Primary B Lymphocytes by Forced Expression of Bach2. | J Immunol | 2021 | https://conductscience.org/library/papers/34389622 | PubMed |
1 to 10 of 109
See all 109 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/97089
GET https://conductscience.org/api/papers/v1/97089/cited_by?page=2